Performance
Trailing returns
| Best 3-month return | +17.98% | |
| Worst 3-month return | -8.47% |
Morningstar statistics
Morningstar category: Global Large-Cap Blend Equity
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 10,590.00 | |
| Front load | 1.00% | |
| Deferred load | - | |
| Expense ratio | - | |
| Management fee | 1.00% | |
| Fund family | Marlborough Fund Managers Limited |
Asset allocation
| Cash | 0.00% | |
| Stocks | 96.94% | |
| Bonds | 0.00% | |
| Other | 3.06% |
Purchase information
| Initial | �50,000 |
1.240.00(0.26%)
Sep 20, 4:00pm BST
Description
The investment objective of the Fund is to maximise capital growth and income. The Fund will invest primarily in a broad range of equities traded on global markets. Such equities will primarily be denominated in pounds Sterling, US dollars and Euros, and the Fund may hedge its currency risk to the extent permitted by COLL. The Fund may also invest in other transferable securities including bonds and warrants, shares and/ or units in collective investment schemes, money market instruments, cash and near cash, and deposits. The Fund may also borrow and employ stocklending and underwriting techniques as permitted in COLL.
Advisor Company:
SGC Asset Management Ltd
SGC Asset Management Ltd
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | - | - | - | - | |
| Beta* | - | - | - | - | |
| Mean annual return | - | - | - | - | |
| R-squared* | - | - | - | - | |
| Standard deviation | - | - | - | - | |
| Sharpe ratio | - | - | - | - | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| Mizuho Financial Group Inc ADR (MFG) | 3.99% | |
| Lloyds Banking Group PLC (LLOY) | 2.96% | |
| Glaxosmithkline (GLAXF) | 2.92% | |
| Pfizer Inc (PFE) | 2.82% | |
| Sangamo BioSciences, Inc. (SGMO) | 2.48% | |
| Albany Molecular Research, Inc. (AMRI) | 2.41% | |
| Aberdeen New Thai Investment Trust | 2.31% | |
| Ashmore Group PLC (ASHM) | 2.29% | |
| Charles River Laboratories International Inc (CRL) | 2.27% | |
| Mitsubishi UFJ Financial Group, Inc. ADR (MTU) | 2.16% |